Suddenly, the US COVID-19 vaccine causes immune disorders in humans

Suddenly, the US COVID-19 vaccine causes immune disorders in humans

At least 36 people receiving the Pfizer and Moderna’s COVID-19 vaccines in the US have developed a rare immune disorder. One patient died. Doctors in the US have not been able to rule out the blame for the vaccine, RT said.

The removal of the COVID-19 My vaccine caused epidemic pain in people
Pfizer vaccine is suspected to be associated with symptoms that prevent blood clotting.

Dr. Gregory Michael – a 56-year-old obstetrician and gynecologist who ran his own clinic at Miami Beach’s Mount Sinai Medical Center for more than a decade – passed away in January of a brain hemorrhage. He had received a Pfizer-BioNTech vaccine two weeks earlier, and immediately developed immune thrombocytopenia, a rare and sometimes fatal blood disorder.

Dr. Michael is one of at least 36 cases to develop the condition after vaccination by Pfizer or Moderna, according to a New York Times report published on February 8. Cases were reported to the government’s Vaccine Adverse Event Reporting System (VAERS) before the end of January, meaning many people may have developed the condition since.

Immune thrombocytopenia is a rare condition that affects an estimated 50,000 people in the US. This condition is caused by the body’s immune system attacking platelets, which are the part of the blood responsible for blood clotting. Because the blood cannot clot, the patient often has internal or external bruising, which may look like a rash. In some cases like Michael’s, this has caused major bleeding or stroke.

One patient the Times linked with had severe vaginal bleeding two weeks after receiving the Moderna vaccine and required a platelet transfusion and steroid therapy to survive.

Another woman was hospitalized with blisters in her mouth and bruising just a day after receiving the same vaccine. Her condition got so bad that doctors were concerned that a light tap would cause fatal bleeding and fear of having to move her from the hospital bed.

The link between the vaccine and the patient’s coagulation is “probable,” said Dr. James Bussel, a hematologist and coagulation specialist.

Immune thrombocytopenia can also develop from certain drugs and cancers, from the flu, and appears to be caused by COVID-19 itself. As early as last spring, long before any vaccines were nearly finalized, doctors in the US, Europe, India and China noticed the condition of the COVID-19 patient above and suspected There is a doubt that there is an association between anticoagulation and the virus that causes COVID-19.

Unlike traditional vaccines, which use the inactive form of the pathogen they protect against, both Pfizer and Moderna’s vaccines are mRNA vaccines. This is a use of new technology and therefore has not been tested on a mass basis, but these vaccines work by introducing a sequence of viral RNA into the body’s cells with instructions for the person’s DNA to know how. begins to generate antibodies.

Researchers at Cambridge University claim that side effects may include an “autoimmune response”, but Harvard scientists say that the mRNA vaccine produces “a stronger immunity” than other their traditional vaccines.

Food and Drug Administration (FDA) and US Centers for Disease Control and Prevention (CDC) officials said they are investigating the VAERS reports, while both Pfizer and Moderna told Times that they are monitoring the safety of the vaccine and cannot talk about individual patient cases.

In fact, Pfizer and Moderna’s vaccines have both reported cases of allergies, anaphylaxis, and facial paralysis.

According to the UK’s National Health Service (NHS), the most common symptoms of an allergic reaction after getting a vaccine are hives, allergic rhinitis such as sneezing, itchy nose, runny or stuffy nose. shortness of breath, cough, conjunctivitis, and watery eyes. Meanwhile, a severe allergic reaction, also known as anaphylaxis, can be life-threatening.

Hai Lam


Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *